May 9 (Reuters) - Radiopharm Theranostics Ltd (RAD) :
- U.S. FDA GRANTED ORPHAN DRUG DESIGNATION TO GA68-TRIVEHEXIN (RAD 301)
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.001(2.78%) |
Mkt cap ! $17.03M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.7¢ | 3.6¢ | $10.27K | 282.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9620 | 3.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 15665 | 2 |
View Market Depth
| Last trade - 12.40pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.6¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 3.7¢ | 3.7¢ | 3.6¢ | 133038 | ||
| Last updated 13.35pm 20/05/2024 ? | |||||
| RAD (ASX) Chart |